161 related articles for article (PubMed ID: 26786167)
1. [Genitourinary malignancies and rheumatoid arthritis].
Boegemann M; Alten R; Aringer M; Zastrow S
Z Rheumatol; 2016 Feb; 75(1):54-62. PubMed ID: 26786167
[TBL] [Abstract][Full Text] [Related]
2. [Disease-modifying antirheumatic drugs in rheumatoid arthritis patients with a history of colorectal cancer].
Kleinert S; Waldner M; Wendler J; Kunzmann V
Z Rheumatol; 2016 Feb; 75(1):41-6. PubMed ID: 26786168
[TBL] [Abstract][Full Text] [Related]
3. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
4. [Gynecological cancers in patients with inflammatory rheumatic diseases].
Schmalzing M; Krockenberger M; Honig A; Tony HP
Z Rheumatol; 2016 Feb; 75(1):63-7. PubMed ID: 26813689
[TBL] [Abstract][Full Text] [Related]
5. Special report: evidence on sequencing of conventional and biological disease-modifying anti-rheumatic drugs.
TEC Bull (Online); 2003 Nov; 20(3):24-9. PubMed ID: 15052992
[No Abstract] [Full Text] [Related]
6. [Rheumatoid arthritis].
Aletaha D; Kerschbaumer A
Z Rheumatol; 2017 Feb; 76(1):8-14. PubMed ID: 28058499
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
Bays AM; Gardner G
Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
[TBL] [Abstract][Full Text] [Related]
8. [The pulmonological manifestations of rheumatoid arthritis].
Bernscherer G; Karabélyos C; Tarján Z
Orv Hetil; 2008 Jul; 149(29):1355-61. PubMed ID: 18617467
[TBL] [Abstract][Full Text] [Related]
9. [Glucocorticoid therapy in rheumatoid arthritis - pro].
Pongratz G
Dtsch Med Wochenschr; 2016 Oct; 141(22):1650. PubMed ID: 27824423
[TBL] [Abstract][Full Text] [Related]
10. [Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].
Krüger K; Edelmann E
Z Rheumatol; 2015 Jun; 74(5):414-20. PubMed ID: 26085073
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of cardiovascular risk factors].
Krüger K
Z Rheumatol; 2016 Mar; 75(2):173-80; quiz 181-2. PubMed ID: 26924198
[TBL] [Abstract][Full Text] [Related]
12. Iguratimod in combination with methotrexate in active rheumatoid arthritis : Therapeutic effects.
Xia Z; Lyu J; Hou N; Song L; Li X; Liu H
Z Rheumatol; 2016 Oct; 75(8):828-833. PubMed ID: 26508503
[TBL] [Abstract][Full Text] [Related]
13. [Rheumatoid arthritis: milestones in classification and treatment].
Fiehn C
Dtsch Med Wochenschr; 2011 Feb; 136(5):203-5. PubMed ID: 21271482
[TBL] [Abstract][Full Text] [Related]
14. [Recommendations on the use of rituximab for ANCA-associated vasculitis].
Gause AM; Rubbert-Roth A;
Z Rheumatol; 2014 Apr; 73(3):287-9. PubMed ID: 27039911
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in the management of rheumatoid arthritis.
Tanaka Y
Korean J Intern Med; 2016 Mar; 31(2):210-8. PubMed ID: 26932398
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.
Umićević Mirkov M; Coenen MJ
Pharmacogenomics; 2013 Mar; 14(4):425-44. PubMed ID: 23438889
[TBL] [Abstract][Full Text] [Related]
17. [Lung cancer and rheumatoid arthritis. An interdisciplinary challenge].
Rubbert-Roth A; Zander T; Kneitz C; Baerwald C; Wirtz H; Witt C
Z Rheumatol; 2016 Feb; 75(1):47-53. PubMed ID: 26838521
[TBL] [Abstract][Full Text] [Related]
18. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
Zink A; Listing J; Ziemer S; Zeidler H;
J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
[TBL] [Abstract][Full Text] [Related]
19. Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up.
Tiippana-Kinnunen T; Paimela L; Kautiainen H; Laasonen L; Leirisalo-Repo M
Scand J Rheumatol; 2010; 39(1):12-8. PubMed ID: 20132065
[TBL] [Abstract][Full Text] [Related]
20. [Malignancies of the skin and immunomodulatory antirheumatic therapy].
Burkhardt H; Weisenseel P; Radtke MA; Krüger K
Z Rheumatol; 2016 Feb; 75(1):32-40. PubMed ID: 26813688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
